These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Mogamulizumab for the treatment of relapsed or refractory adult T-cell leukemia-lymphoma. Winsett FT; Lewis DJ; Duvic M Expert Rev Hematol; 2017 Sep; 10(9):757-760. PubMed ID: 28756726 [TBL] [Abstract][Full Text] [Related]
27. Successful treatment strategy in corporating mogamulizumab and cord blood transplantation in aggressive adult T-cell leukemia-lymphoma: a case report. Nakata K; Fuji S; Koike M; Tada Y; Masaie H; Yoshida H; Watanabe E; Kobayashi S; Tojo A; Uchimaru K; Ishikawa J Blood Cell Ther; 2020 Feb; 3(1):6-10. PubMed ID: 37465376 [TBL] [Abstract][Full Text] [Related]
28. Clinical Impact of a Humanized CCR4 Antibody (Mogamulizumab) in 14 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated at a Single Institution During a Three-year Period (2012-2014). Kawano N; Kuriyama T; Sonoda KH; Yoshida S; Yamashita K; Ochiai H; Shimoda K; Ishikawa F; Ueda A; Kikuchi I Intern Med; 2016; 55(11):1439-45. PubMed ID: 27250049 [TBL] [Abstract][Full Text] [Related]
29. Recurrence of Psoriasis Vulgaris Accompanied by Treatment with C-C Chemokine Receptor Type 4 (CCR4) Antibody (Mogamulizumab) Therapies in a Patient with Adult T cell Leukemia/ Lymphoma: Insight into Autoinflammatory Diseases. Morichika K; Tomoyose T; Hanashiro T; Shimabukuro N; Tamaki K; Tedokon I; Nishi Y; Nakachi S; Karube KN; Fukushima T; Katoh T; Ohshima K; Masuzaki H Intern Med; 2016; 55(10):1345-9. PubMed ID: 27181545 [TBL] [Abstract][Full Text] [Related]
36. [Development of Tax-redirected T-cell immunotherapy using TCR gene transduction in patients with ATL]. Tanaka Y; Kanda Y Rinsho Ketsueki; 2015 Jul; 56(7):815-24. PubMed ID: 26251144 [TBL] [Abstract][Full Text] [Related]
37. CCR7 alterations associated with inferior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment. Sakamoto Y; Ishida T; Masaki A; Murase T; Ohtsuka E; Takeshita M; Muto R; Iwasaki H; Ito A; Kusumoto S; Nakano N; Tokunaga M; Yonekura K; Tashiro Y; Iida S; Utsunomiya A; Ueda R; Inagaki H Hematol Oncol; 2022 Dec; 40(5):876-884. PubMed ID: 36043457 [TBL] [Abstract][Full Text] [Related]
38. Outcome of allogeneic hematopoietic cell transplantation in patients with adult T-cell leukemia. Kamiunten A; Sekine M; Kameda T; Akizuki K; Tahira Y; Shide K; Shimoda H; Kato K; Hidaka T; Kubuki Y; Shimoda K Hematol Oncol; 2018 Oct; 36(4):651-655. PubMed ID: 30117169 [TBL] [Abstract][Full Text] [Related]
39. Small number of HTLV-1-positive cells frequently remains during complete remission after allogeneic hematopoietic stem cell transplantation that are heterogeneous in origin among cases with adult T-cell leukemia/lymphoma. Yamasaki R; Miyazaki Y; Moriuchi Y; Tsutsumi C; Fukushima T; Yoshida S; Taguchi J; Inoue Y; Matsuo E; Imaizumi Y; Imanishi D; Fujimoto T; Tsushima H; Honda S; Hata T; Tsukasaki K; Tomonaga M Leukemia; 2007 Jun; 21(6):1212-7. PubMed ID: 17410191 [TBL] [Abstract][Full Text] [Related]
40. Mogamulizumab for the Treatment of Adult T-cell Leukemia/Lymphoma. Ureshino H; Kamachi K; Kimura S Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):326-331. PubMed ID: 30981611 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]